Clinical obstetrics and gynecology, 59(1), 2-24, 2016

Epidemiology of Uterine Fibroids: From Menarche to Menopause

Lauren A Wise , Laughlin-Tommaso SK

Author affiliations
  • Slone Epidemiology Center at Boston University, Boston, Massachusetts and 2Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia ROR
DOI10.1097/GRF.0000000000000164 PMID26744813
Read at source

Abstract

Uterine leiomyomata (UL) have a substantial impact on women's health, but relatively few studies have identified opportunities for primary prevention of these neoplasms. Most established risk factors are not modifiable, including premenopausal age, African ancestry, age at menarche, and childbearing history. The main challenge in studying UL is that a large proportion of tumors are asymptomatic. Herein, we review the epidemiology of UL from published studies to date. We highlight the advantages of ultrasound screening studies and the ways in which their innovative methods have helped clarify the etiology of disease. We conclude with a discussion of promising new hypotheses.

PMID 26744813 26744813 DOI 10.1097/GRF.0000000000000164 10.1097/GRF.0000000000000164

Cite this article

Wise, L. A., & Laughlin-Tommaso, S. K. (2016). Epidemiology of Uterine Fibroids: From Menarche to Menopause.. *Clinical obstetrics and gynecology*, *59*(1), 2-24. https://doi.org/10.1097/GRF.0000000000000164